Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-09-05
1991-12-24
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, 530351, A61K 3702, A61K 3718, C07K 704, C07K 1300
Patent
active
050752880
ABSTRACT:
A protein fragment for inducing sleep in mammals comprising a fragment of interleukin-1 .beta. from about amino acid 208 to about amino acid 240 and its physiologically active derivatives. The fragment comprises the amino acids sequence: ##STR1## The protein fragment may be derived by synthetic methods and a cysteine residue may be attached to the last threonine residue.
REFERENCES:
patent: 2575763 (1951-11-01), Menkin
patent: 4116949 (1978-09-01), Goodman et al.
patent: 4537878 (1985-08-01), Plotnikoff
patent: 4668661 (1987-05-01), Karnovsky et al.
patent: 4762914 (1988-08-01), Auron et al.
patent: 4766069 (1988-08-01), Auron et al.
patent: 4801686 (1989-01-01), Kronheim
patent: 4808611 (1989-02-01), Cosman
patent: 4902505 (1990-02-01), Pardridge et al.
patent: 4935343 (1990-06-01), Allison et al.
patent: 4994553 (1991-02-01), Schmidt et al.
M. Opp, American Journal of Physiology 257: R528-R535, 1989.
Krueger James M.
Obal, Jr. Ferenc
Postlethwaite Arnold E.
Seyer Jerome M.
Russel Jeffrey E.
The University of Tennessee Research Corporation
Walsh Stephen
LandOfFree
Somnogenic fragment of interleukin-1.beta. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Somnogenic fragment of interleukin-1.beta., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somnogenic fragment of interleukin-1.beta. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-43497